NCT07453394 2026-03-06
QLS5132 Combination Therapy in Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
Qilu Pharmaceutical Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Jiangsu Cancer Institute & Hospital
Tongji Hospital
Assiut University
Peking Union Medical College Hospital
Endeavor Health
Zhongnan Hospital
Sun Yat-sen University
Fujian Cancer Hospital
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Aston Sci. Inc.
Fudan University